BRPI0811860A2 - Compostos de (fenil)imidazolil)metilheteroarila - Google Patents

Compostos de (fenil)imidazolil)metilheteroarila

Info

Publication number
BRPI0811860A2
BRPI0811860A2 BRPI0811860-4A2A BRPI0811860A BRPI0811860A2 BR PI0811860 A2 BRPI0811860 A2 BR PI0811860A2 BR PI0811860 A BRPI0811860 A BR PI0811860A BR PI0811860 A2 BRPI0811860 A2 BR PI0811860A2
Authority
BR
Brazil
Prior art keywords
methyleteroaril
imidazolil
phenyl
compounds
methyleteroaril compounds
Prior art date
Application number
BRPI0811860-4A2A
Other languages
English (en)
Portuguese (pt)
Inventor
Santosh C Sinha
Todd M Heidelbaugh
Ken Chow
Smita S Bhat
Phong X Nguyen
Michael E Garst
Original Assignee
Allergan Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Allergan Inc filed Critical Allergan Inc
Publication of BRPI0811860A2 publication Critical patent/BRPI0811860A2/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/41641,3-Diazoles
    • A61K31/41781,3-Diazoles not condensed 1,3-diazoles and containing further heterocyclic rings, e.g. pilocarpine, nitrofurantoin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00Anaesthetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/06Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Anesthesiology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
BRPI0811860-4A2A 2007-05-14 2008-05-13 Compostos de (fenil)imidazolil)metilheteroarila BRPI0811860A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US91783307P 2007-05-14 2007-05-14
PCT/US2008/063489 WO2008141312A1 (en) 2007-05-14 2008-05-13 ((phenyl)imidazolyl)methylheteroaryl compounds

Publications (1)

Publication Number Publication Date
BRPI0811860A2 true BRPI0811860A2 (pt) 2014-11-18

Family

ID=39683865

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0811860-4A2A BRPI0811860A2 (pt) 2007-05-14 2008-05-13 Compostos de (fenil)imidazolil)metilheteroarila

Country Status (16)

Country Link
US (1) US20100273814A1 (enExample)
EP (1) EP2155715B1 (enExample)
JP (1) JP5323059B2 (enExample)
KR (1) KR20100031502A (enExample)
CN (1) CN101743240B (enExample)
AU (1) AU2008251324B2 (enExample)
BR (1) BRPI0811860A2 (enExample)
CA (1) CA2687303C (enExample)
DK (1) DK2155715T3 (enExample)
ES (1) ES2402746T3 (enExample)
IL (1) IL202137A0 (enExample)
MX (1) MX2009012349A (enExample)
NZ (1) NZ599554A (enExample)
RU (1) RU2478631C2 (enExample)
WO (1) WO2008141312A1 (enExample)
ZA (1) ZA200908088B (enExample)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009091735A1 (en) * 2008-01-18 2009-07-23 Allergan.Inc Substitued-aryl-(imidazole)-methyl)-phenyl compounds as subtype selective modulators of alpha 2b and/or alpha 2c adrenergic receptors
JP2019517524A (ja) * 2016-06-02 2019-06-24 パーデュー ファーマ エルピー 疼痛治療のための微量アミン関連受容体1アゴニスト及び部分アゴニスト
WO2024220941A1 (en) * 2023-04-21 2024-10-24 Alceptor Therapeutics, Inc. Triaryl agonists of alpha-2 adrenergic receptors
WO2024226608A2 (en) * 2023-04-25 2024-10-31 Aglaeapharma Inc. Imidazole containing compounds, derivatives therefore, and uses thereof

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5098811A (en) * 1988-09-22 1992-03-24 Minolta Camera Kabushiki Kaisha Ioner for developing electrostatic latent image comprising specified imidazoles
US5750720A (en) * 1996-03-28 1998-05-12 Ortho Pharmaceutical Corporation 4- (thien-3-yl)methyl!-imidazole analgesics
US6841684B2 (en) * 1997-12-04 2005-01-11 Allergan, Inc. Imidiazoles having reduced side effects
TWI283669B (en) * 1999-06-10 2007-07-11 Allergan Inc Compounds and method of treatment having agonist-like activity selective at alpha 2B or 2B/2C adrenergic receptors
BRPI0516025A (pt) * 2004-09-24 2008-08-19 Allergan Sales Inc 4-(heteroaril-metil e heteroaril-metil substituìda)-imidazol-2-tionas que atuam como agonistas alfa2 adrenérgicos

Also Published As

Publication number Publication date
JP2010527369A (ja) 2010-08-12
CN101743240B (zh) 2013-07-17
JP5323059B2 (ja) 2013-10-23
AU2008251324B2 (en) 2014-05-01
RU2009145817A (ru) 2011-06-20
WO2008141312A1 (en) 2008-11-20
AU2008251324A1 (en) 2008-11-20
CN101743240A (zh) 2010-06-16
EP2155715A1 (en) 2010-02-24
DK2155715T3 (da) 2013-05-13
IL202137A0 (en) 2010-06-16
US20100273814A1 (en) 2010-10-28
MX2009012349A (es) 2009-12-01
NZ599554A (en) 2013-12-20
EP2155715B1 (en) 2013-03-13
CA2687303A1 (en) 2008-11-20
KR20100031502A (ko) 2010-03-22
RU2478631C2 (ru) 2013-04-10
CA2687303C (en) 2015-05-05
ES2402746T3 (es) 2013-05-08
ZA200908088B (en) 2010-12-29

Similar Documents

Publication Publication Date Title
LTPA2020501I1 (lt) Pakeistieji enaminokarbonilo junginiai
BRPI0813500A2 (pt) Compostos antivirais
BRPI0821086A2 (pt) Compostos inseticidas
DK2185567T3 (da) Substituerede bicyclolactam-forbindelser
BRPI0815042A2 (pt) Compostos de pirazol
ATE524477T1 (de) Aziridinylepothilonverbindungen
LU92600I2 (fr) Sovaldi (sofosbuvir)
BRPI0811264A2 (pt) Compostos
EP2044055A4 (en) amide compounds
BRPI0810250A2 (pt) Compostos inéditos
BRPI0920707A2 (pt) compostos
BRPI0821627A2 (pt) Compostos químicos
DK2242759T3 (da) Forbindelser
BRPI0814601A2 (pt) compostos químicos
EP1985620A4 (en) COMPOUND 10a-AZALIDE
BRPI0914775A2 (pt) compostos de fenila dissubstituídos
BRPI0814424A2 (pt) Compostos heterociclila
BRPI0809996A2 (pt) Compostos
DK2235041T3 (da) Antimikrobielle forbindelser
EP2208972A4 (en) COMBINATION SCALE
BRPI0814411A2 (pt) Compostos químicos
BRPI0916432A2 (pt) compostos
BRPI0815181A2 (pt) Compostos
BRPI0814613A2 (pt) Compostos
LT3825306T (lt) Morfinano junginiai

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 8A ANUIDADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2385 DE 20-09-2016 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.